MarketRippa logo MarketRippa

14 May 2026 - Top Stories

Coverage across health, digital health, funding, and policy developments in Australia.

Daily digest

21 articles

Methodology: This digest condenses the source coverage listed below for faster scanning by Australian health teams. It is not medical advice.

MRFF uplift to 1 billion dollars per year by 2030–31 concentrates government medical research funding on a clearer planning path.

Australia’s Budget lifts MRFF disbursements to 1 billion annually by 2030–31, with 508.5 million over four years held in Contingency Reserve until the National Health and Medical Research Strategy is finalised. The move strengthens government science funding amid rising costs and global competition and should stabilise momentum in research and innovation. For health tech executives, it promises clearer translational pipelines and longer planning horizons, though immediate access and indirect cost coverage remain uncertain.

A DHCRC and RMIT analysis flags a persistent shortfall of Clinical Information Modelling professionals. The 11 recommendations push for a National CIM Framework and formal CIM training embedded in university and provider curricula. As HL7 FHIR adoption grows, the risk of fragmentation looms if workforce development does not keep pace. RMIT will add a CIM focused module to Health Informatics, making it the first of its kind. For health IT teams, this creates demand for CIM knowledge and integrated governance.

Healthed/HSD surveys 18.7 percent of Australian GPs personally using AI scribes in consultations, with a substantial share of non users seriously considering adoption. The framing of questions explains divergent clinic wide uptake in other polls. The result is a signal that AI assisted documentation will become more common, requiring governance and integration with EMRs. For vendors and early adopting practices, a win is faster productivity and better data capture; for slower clinics, productivity gaps may widen.

Visionflex and MMEx announced an integration that embeds virtual consultations in the MMEx EMR. Clinicians can initiate virtual visits and push vitals data directly into the patient chart using HL7 and FHIR standards. The integration reduces workflow friction for MMEx users and Visionflex customers while standalone telehealth tools lose advantage. The longer term test is data governance across cross‑platform workflows and whether uptake will be sustained in busy practices.

Value based funding gains traction in the US while Australia lags. The argument is for prevention oriented payment models and interoperable data coalitions that reward outcomes rather than service volume. For health tech executives this frames a clear decision point to build or join interoperable data networks to support prevention and population health. The risk is continued inefficiency without reform and a widening gap between early adopters and late adopters.

  • The federal government approves the MRFF uplift, providing more predictable funding cycles for health tech translational projects.
  • DHCRC and RMIT release 11 CIM recommendations, creating demand for CIM training and better interoperability.
  • GPs using AI scribes gain productivity benefits and drive demand for governance-ready AI tools integrated with EMRs.
  • Visionflex and MMEx integrate virtual visits into the MMEx EMR, giving clinics a seamless remote care workflow.
  • Federal government and Cohealth commit $1.5 million each to sustain general practice services for 12 months, preserving continuity in targeted Melbourne clinics.
  • Pharmacy Board launches public consultation on pharmacist prescribing until 15 June, with endorsement requiring prescribing workflows to be integrated in health records.